BN Business News
Add your company to Business Communicator →

Regulation & law · 15/11/2005Updated: 10/17/2026 · 1 min read

Polydex Pharmaceuticals Limited Withdraws Common Stock from Boston Stock Exchange

Summary

Polydex Pharmaceuticals Limited has submitted a notice to withdraw its common stock with a par value of $0.0167 from listing and registration on the Boston Stock Exchange, Inc.

Original source language: Federal Register — All DocumentsOpen original release →

Explore insights

Business insights →